Ascidians are well known to accumulate extremely high levels of vanadium in their blood cells.
Abstract
Ascidians are well known to accumulate extremely high levels of vanadium in their blood cells.
Several key proteins related to vanadium accumulation and physiological function have been isolated from vanadium-rich ascidians. Of these, vanadium(IV)-binding protein-129 (VBP-129) is a unique protein that has been identified from the blood plasma of an ascidian Ascidia sydneiensis samea, but its metal binding domains are not known. In this study, several deletion and point mutants of VBP-129
were generated, and their metal binding abilities were assessed by immobilized metal ion affinity chromatography (IMAC) and electron spin resonance spectroscopy (ESR). The internal partial protein, VBP-Int41, did not bind to V IV , but the two constructs, VBP-N52 and VBP-Int55, added with additional 11 or 14 neighboring amino acids bound to V IV . Mutations for cysteine-47 and lysine-50 in VBP-Int55 diminished V IV -binding in VBP-Int55, suggesting that these amino acid residues play important roles in binding V IV . ESR titration analysis revealed that VBP-129, VBP-N52 and VBP-Int55 could bind to 6, 3 and 2 V IV ions, respectively. ESR spectrum analysis indicated a N 2 O 2 coordination geometry, which is similar to Vanabins. The cysteines may contribute to the maintenance of the three-dimensional structure that is necessary for binding V IV ions. VBP-129 did not have a V V -reductase activity, as expected from its tissue localization in blood plasma. This study provided the evidences that VBP-129 possesses V IV -binding domains that make a similar coordination to V IV as
Introduction
The unusual ability of ascidians to accumulate high levels of vanadium ions has been attracting attention in biological and chemical disciplines for a century [1] . during assimilation [2, 3] . Additionally, most vanadium ions are stored in the vacuoles of signet ring cells, a type of blood cell, and are often referred to as vanadocytes [4, 5] .
Ongoing research over the last two decades has identified many proteins involved in the process of accumulating and reducing vanadium in vanadocytes, blood plasma, and the digestive tract of ascidians, such as vacuolar-type H + -ATPase [6] [7] [8] , the chloride channel [9] , the sulfate transporter [10] , enzymes of the pentose-phosphate pathway [11] [12] [13] [14] , the glutathione transferase [15] , Vanabins [16] [17] [18] , and a vanadium transporter [19] . [20] .
A truncated form of VBP-129 that does not bind to V IV was also discovered, which has been called VBP-88 for its lack of 41 amino acid residues [20] . But, the properties such as binding number and coordination geometry in VBP-129 have not been revealed.
In this study, we sought to reveal the position and property of V IV -binding domain(s) of VBP-129 as well as the contribution of crucial amino acids for the binding of V IV . According to the differential sequence between full-length VBP-129 and its spontaneous truncated form VBP-88, several deletion and point mutants of VBP-129 were created using PCR amplification and in vitro site-directed mutagenesis. Their metal binding abilities were assessed by IMAC and ESR. ESR measurements were conducted to reveal binding number and coordination geometry of V IV to VBP-129. Since reductase activity was not detected, VBP-129 seemed to act solely as a V IV -carrier protein in blood plasma.
Material and methods

Construction of expression plasmids
Deletion mutants of VBP-129 were constructed by PCR amplification using a VBP-129 expression plasmid [20] as the template. Primer sets and templates used are listed in Table 1 . PCR reactions consisted of 100 ng plasmid DNA, 200 pmol of each primer, each dNTP at 0.2 mM, 1× reaction buffer, and 2.5 units of Taq DNA polymerase (TaKaRa, Inc.) in a total volume of 50 µL.
Amplification was performed with an initial denaturation at 94°C for 2 min, 30 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s, and a final extension at 72°C for 5 min. After purification by agarose gel electrophoresis and cloning into pBluescript/EcoRV/dT vector, the nucleotide sequence was confirmed using an ABI 3130 automated DNA sequencer (Applied Biosystems Japan Ltd.) at the Natural Science Center for Basic Research and Development, Hiroshima University (N-BARD).
Each plasmid DNA was digested with restriction enzymes to excise the amplified fragments.
These fragments were ligated into the multiple cloning sites of the expression vector pMAL-c2X
(New England BioLabs), which contains the lac promoter and a coding region for MBP. Each plasmid was introduced into Escherichia coli BL21 for protein expression.
Plasmid vector and host E. coli strain for expressing another vanadium-binding protein, Vanabin1, were the same ones as used in our previous work [16] .
In vitro site-directed mutagenesis
Site-directed mutagenesis of the coding region of VBP-129 and VBP-Int55 was conducted by a PCR-based in vitro procedure based on the manufacturer's protocol as described previously [21] , using the plasmid vectors pMal-p2X with the VBP-129 insert and pMal-c2X with the VBP-Int55 insert as templates. The combination of primer sets and template DNAs are listed in Table 1 . Target residues were cysteine-47 (TGC) and lysine-50 (AAA) in the VBP-Int55 amino acid sequence, and cysteine-80 (TGC) and lysine-83 (AAA) in the VBP-129 amino acid sequence (Fig. 1) . The cysteine and lysine were substituted by serine (AGC) and alanine (GCA), respectively. Each primer pair had a mutagenizing codon, which was flanked by complementary regions of 9-12 nucleotides. 
Recombinant protein expression
Recombinant proteins were prepared as described previously [20] . Briefly, E. coli cells transformed with each plasmid DNA were incubated overnight at 37°C in 200-mL LB-Amp medium containing ampicillin (50 µg/mL). After dilution with 1,800-mL fresh LB-Amp medium, 0.1 mM IPTG was added and the culture was incubated at 37°C for 6 h. was washed three times with water and mixed with each metal solution in a 2.0-mL plastic tube for 15 min (125 µL bed volume per each tube). The resin was washed three times with DW and twice with binding buffer (100 mM NaCl, 20 mM Na 3 PO 4 , pH 7.2). The protein in the binding buffer (~300 µg/mL, 500 µL) was mixed with the resin by rotation for 30 min at 4°C. Non-bound proteins were removed by centrifugation and the resin was washed three times with binding buffer. Bound proteins and metal ions were eluted with elution buffer (100 mM NaCl, 20 mM Na 3 PO 4 , 50 mM EDTA, pH 8.0, 400 µL). Non-bound and bound protein fractions were analyzed by SDS-PAGE and CBB staining.
ESR measurements
ESR measurements on Vanabin1 were done according to our previous study [22] , while measurements on VBP-129 and its derivatives were done by a slightly modified protocol as described below.
In the binding assay on VBP-129, proteins were dialyzed against a buffer (100 mM NaCl, 10 mM Tris-HCl, pH 7.5; here we term it as a buffer A). Vanadyl sulfate (V IV ; VOSO 4 ·n H 2 O, n = 3-4)
was dissolved in DW at 1 mM immediately prior to use. After mixing the proteins with the appropriate amount of 10×concentrated stock of the buffer A, the vanadium solution was added and the mixture was incubated for 5 -10 min at room temperature. Longer incubation up to 3 h did not gave any significant changes in ESR spectrum. The mixture was placed in a quartz tube (5 × 100 mm, ST-X-5, Agri Co.) and frozen immediately in liquid nitrogen. ESR signals were recorded using the ELEXSYS-II E500 CW-ESR (Bruker BioSpin) with ER 4112V temperature control system at the N-BARD. The sample was inserted into the quartz dewar, which was held in a steam of temperature controlled nitrogen gas. ESR measurements were done at 78 -80 K with a frequency of 9.4 GHz and a modulation (100 kHz) of 1 mT. Modulation amplitude was 10G, and receiver gain was 60 dB.
Conversion time was 15ms. Microwave attenuation was 25 dB, and microwave power was 0.6325W.
Number of scan was 3 times. There have been no significant differences among spectra recorded between 78 and 80 K. ESR parameters (A || , g || ) were obtained from the spectrum.
In the reduction assay on VBP-129, sodium orthovanadate (99.98% Na 3 VO 4 , Sigma Aldrich) was dissolved in DW at 10 mM. The yellowish solution was incubated at 60°C until it became colorless. The protein solution was mixed with vanadate solution and the appropriate amount of 10×concentrated stock of the buffer A to give the same buffer composition as the buffer A (100 mM NaCl, 10 mM Tris-HCl, pH 7.5). The mixed solution was incubated at 20°C for 8 h. The solution was then frozen in liquid nitrogen and ESR signals were recorded as described above.
Determining V IV -binding parameters from ESR intensities
For determining the binding number and dissociation constant for V IV and a protein, relative ESR intensity for a specific resonance was integrated from each ESR spectrum. Assumed that a protein possesses multiple V IV -binding sites (n), a portion of the sites (q) were occupied by the metal ions by equilibrium. Using the total concentrations of vanadium (v) and protein (p), the dissociation constant (K d ) can be calculated with the following equation:
At physiological pH and in the absence of coordinating ligands, free V IV is ESR-silent due to the formation of vanadyl hydroxides with various stoichiometries [25] . As shown in Fig. 4A , non-protein-bound V IV ions give little signal at the position of 3/2 ┴ peak. Therefore, we chose this peak for intensity analysis. Assuming free vanadium ions were in excess and signals from non-protein-bound V IV ions can be neglected at this pH [25] , ESR signal at 3/2 ┴ is mostly derived from the occupied sites (q). Therefore, ESR intensity (I) can be approximated to be proportional to q:
In this equation, c is a coefficient to normalize the ESR intensity. By varying v and p, experimental data were obtained for I. Then, the best-fitting parameters, c, n and K d , were calculated by repeating Monte Calro algorithm using the Pro Fit software running on a Macintosh OSX (QuantumSoft, Switherland).
Results
Metal-binding ability of VBP-Int41, VBP-N52 and VBP-Int55
In the previous study, a truncated form of VBP-129 that does not bind to V IV was discovered. It has been called VBP-88 for its lack of internal 41 amino acid residues [20] . We thought it should be a starting point to reveal V IV -binding domain(s) in VBP-129. In this study, a recombinant protein with the internal 41-amino-acid sequence between VBP-129 and VBP-88 was first constructed (VBP-Int41; Fig. 1 (Fig. 2) . This result suggested that the internal sequence, VBP-Int41, was insufficient for binding of
Given that VBP-Int41 did not bind to V IV , we hypothesized that neighboring amino acids were necessary for its binding. To test this, we constructed VBP-N52 and VBP-Int55 recombinant proteins by adding neighboring amino acids to VBP-Int41 (Fig. 1) . VBP-N52 extends up to the N-terminus of mature VBP-129 by adding 11 amino acid residues. The VBP-Int55 sequence included 14 amino acids that cover the putative α-helical region. Both proteins were applied to IMAC and were found to have an ability to bind V IV as well as to Co (Fig. 2) . This data suggested that 52 or 55 amino acid regions are sufficient for V IV -binding.
Metal-binding abilities of VBP-Int55 and VBP-129 with point mutations
We To test whether these two amino acid residues were responsible for V IV -binding in the full-length VBP-129, we created the mutants VBP-129(C80S) and VBP-129(K83A (Fig. 3 ). This spectrum of selectivity was similar to the original VBP-129. Thus, the mutation in lysine-83 did not affect the overall ability of VBP-129 to bind V IV ions and its binding differed from VBP-Int55(K50A (Fig. 3) . This suggested that the mutated cysteine-80 affected the overall ability of VBP-129 to bind V IV ions.
ESR measurement of V IV -binding in VBP-129 and its deletion mutants
ESR measurements were performed to determine binding number and dissociation constants between VBP-129 and V IV ions. A constant concentration (14 µM) of VBP-129 was mixed with 0-150 µM V IV in a buffer containing 100mM NaCl and 10 mM Tris-HCl, pH 7.5. Results showed that the complex V IV -VBP-129 invariably exhibited a normal mononuclear-type V IV signal (Fig. 4) . At physiological pH and in the absence of coordinating ligands, free V IV is ESR-silent due to the formation of vanadyl hydroxides with various stoichiometries [25] , and the ESR signals are from protein-bound V IV . The protein-only sample showed a very weak signal due to crystal imperfections of quartz of the temperature regulating equipment, and the intensity of which was subtracted before calculating the intensity. The curve fitting data indicated that VBP-129 can bind up to 5.6 vanadium per protein with a dissociation constant of 3.8 × 10 -6 M (Fig. 5A , Table 2 ). The ESR parameters of V IV -VBP-129 were g || = 1.952 and A || = 168.3×10 -4 cm -1 ( ) was closest to the measured A || value. It is possible that histidine(s) and tyrosine(s) could contribute as binding site(s), but the number of these amino acids in VBP-129 are not enough to make a binding model that could explain a uniform increase of ESR intensity without changing A || . But still, it is possible that histidine can contribute some of the binding sites because the contribution of imidazole nitrogen of a histidine to A || is similar to that of a lysine [26] .
We have also performed the same ESR analysis on the two deletion mutants, VBP-N52 and VBP-Int55 ( Fig. 5B and 5C ). Here we also describe the ESR data for another vanadium-binding protein Vanabin1 isolated from the same ascidian species (Fig. 5D ) [16] . The results were summarized in Tables 2 and 3 . The coordination geometry of V IV in both proteins were similar to original VBP-129.
It is also similar to that of Vanabin1 as determined here, and that of Vanabin2 [22] .
Reduction of V V by VBP-129
Recently, our group reported that Vanabin2 can act as a V V -reductase in a thiol-disulfide exchange reaction cascade that included GSH and NADPH [27] . To examine the possibility that such a reduction can occur in blood plasma, we performed ESR analysis to examine V V -reductase activity of VBP-129 as described previously. The reaction cascade in this analysis corresponded to the right half of the cascade (Fig. 4 in ref. 27) starting from reduced GSH through the reduction of V V .
When orthovanadate was incubated with glutathione at 20°C for 8 h, we observed some signals which is different from that of V IV (Fig. 6B, D) . We could not attribute the signals to any components.
The mixture composition (Fig. 6B ) was essentially same as that in our previous work ( When 10 µM of VBP-129 was included in each reaction, the resulting peaks were not significantly different from those without VBP-129 (Fig. 6A, C) . The mixture composition was same as that in our previous study (Fig. 3A spectrum 3 
Discussion
Most of the vanadium ions accumulated in ascidians are ultimately localized in the vacuoles of vanadocytes [5] . However, the mechanism by which these ions are taken in before entry into these cells has not been completely determined. Vanadium-binding proteins found in the digestive system, AsGST [15, 28] , and those in blood plasma, VanabinP and VBP-129 [18, 20] , presumably play important roles in the accumulation process. The present study focused on the vanadium-binding protein in blood plasma (VBP-129) and its truncated form (VBP-88), which were suitable starting points to identify V IV -binding domains, based on the affinity for V IV ions in the former, but the lack of binding in the latter [20] . In this study, we constructed several deletion and point mutants of VBP-129, examined the V IV -binding properties of them, and found that VBP-129 binds up to 6 V IV ions in the N 2 O 2 coordination geometry. We also found that VBP-129 does not act as V V -reductase.
The 41-amino-acid region found in VBP-129, but not in VBP-88, was named VBP-Int41 (Fig. 1) . As shown in Figure 2 , VBP-Int41 could not bind V IV , but did bind Co ), is common to vanadium-binding proteins in ascidians. It should be noted that the additivity of A || is not unique and further studies should be used to confirm the assignments.
ESR spectrometry has been extensively used to determine the coordination environment around V IV in several vanadium-binding proteins identified from other animals. Table 3 summarizes the axial parameter data on the proteins whose X-band ESR parameters are obtained in a frozen aqueous solution [22, [29] [30] [31] . The parameters for VBP-129 are close to those of other vanadium-binding proteins, Vanabin1 and Vanabin2 [22] , found in the same species of ascidian. They are also close to A site of human transferrin [29, 32, 33] . Although the coordination geometry for Fe III in this site has been revealed to be Tyr:His:Asp:hydrogencarbonate=2:1:1:1 by X-ray crystalography [34, 35] and the site is common to V IV and Fe III [33] , it is still not clear whether same set of amino acid residues bind to both V IV and Fe III at this site. could be possible. We have found in our previous study that recombinant VBP-129 could polymerize [20] , but the relationship between polymerization and metal-binding is not clear.
In vitro
Cysteines are involved in the maintenance of structure and V V -reduction in Vanabin2, which contains 18 cysteines. In this study, mutagenesis studies suggested that cysteine-47 in VBP-Int55
(cysteine-80 in VBP-129) plays an important role in binding V IV (Fig. 3) and VBP-129 did not act as a V V -reductase (Fig. 6 ). According to ESR parameter analysis (Table 3) , the role of this cysteine residue is not as a V IV -binding site. Thus, the cysteines may contribute to the maintenance of the three-dimensional structure that is necessary for binding V IV ions. Future studies are recommended to determine the status of disulfide bridges in VBP-129.
VBP-129 can interact with VanabinP, which can bind both V IV and V V ions [18] . VBP-129 and
VanabinP form a stable complex, regardless of metal conditions [20] . Although transfer of vanadium ions between VBP-129 and VanabinP has not been determined, these two proteins may act together to deliver V IV ions. V V reduction by VanabinP and subsequent cooperative transport of V IV by a VanabinP-VBP-129 complex could occur and to be determined in future studies.
Identifying the domain responsible for protein-protein interaction with VanabinP is also needed to further understand the transport mechanism. We were unable to develop a model of the protein structure because no suitable base model was found for VBP-129. We are currently developing solutions to determining the three-dimensional structure experimentally by NMR, which will help us to better understand structure-function relationships.
Approaches such as deletion and point mutagenesis are frequently used to identify protein domains or regions responsible for specific function. In vitro point mutagenesis studies are too numerous to be fully elaborated. Studies on the function of N-terminal metal binding sites in P 1B -type ATPases, such as Wilson and Menkes proteins in humans, are good examples of the use of deletion mutagenesis [36] . Copper binding sites in amyloid β protein were also extensively studied by a series of deletion mutants [37] . The domains for binding to DNA by nuclear proteins, protein-protein interaction, and secretion have also been studied using this technique [38] [39] [40] . These approaches are complementary to determining three-dimensional structure and help establishing structure-function relationships.
In ). Because we did not obtain any evidence of V V reduction by VBP-129, it was suggested that VBP-129 acts solely as a V IV -carrier in blood plasma that delivers V IV ions to target proteins in some tissue(s) or cell(s). b) Template plasmid DNAs are derived from the previous study [20] . Recombinant proteins were applied to IMAC charged with metal ions indicated at the top or without any metal ions (-), respectively, and were examined as in Fig. 2 . Arrowheads indicate the protein bands. Table 2 . 
Abbreviations
